Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone
| Conditions | Phase | Intervention Type |
|---|---|---|
| N/A |
|
Eligibility
- Ages Eligible for Study
- 18 years to 75 years
- Genders Eligible for Study
- Both
Keywords
hyperalgesia, Patient controlled analgesia, morphine, methadone, and ketamine
Sponsors
- Other
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Inclusion Criteria
- patients undergoing open colo-rectal surgery
Exclusion Criteria
- ASA status more than II, history of chronic pain, ischemic heart disease or chronic
pulmonary disease, allergy to any drugs used in the protocol. Body Max Index more
than 35.
Detailed Description
Background: In perioperative period inhibition of N-Methyl-D-Aspartate receptor prevents opioid-induced hyperalgesia and reduce postoperative opioid requirement after abdominal surgery. Methadone is both a µ-opioid receptor agonist like Morphine and a N-Methyl-D-Aspartate antagonist. Study Aim. To evaluate the efficacy of intraoperative Ketamine and postoperative Methadone analgesia in preventing opioid-induced hyperalgesia after abdominal surgery.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01594047
Overall Contact
Overall Contact Backup
Locations
-
Fondazione IRCCS Istituto Nazionale dei TumoriMilano, Italy(Recruiting)